Evidence map›Paper›PMID 39391310›Full record

ArticleFrontiers in immunology2024

Higher frequency of peripheral blood CD103

Lian Liu, Wenpu Lai, Xiaoling Zhuo, Sihui Chen, Xiaodan Luo, Huo Tan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. The Proximity of PD-1Cancers · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lian Liu *Guangzhou Medical University, Guangzhou, China.
Wenpu Lai *Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China.
Xiaoling ZhuoFlow Morphology Group, Special Testing Technology Center, Guangzhou Huayin Medical Testing Center Special Testing Technology Center, Guangzhou, China.
Sihui ChenGuangzhou Medical University, Guangzhou, China.
Xiaodan LuoGuangzhou Medical University, Guangzhou, China.
Huo TanGuangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Leukemia is a prevalent pediatric life-threatening hematologic malignancy with a poor prognosis. Targeting immune checkpoints (ICs) to reverse T cell exhaustion is a potentially effective treatment for leukemia. Tissue resident memory T (T Methods: We employed multi-color flow cytometry to evaluate the frequencies of CD103 Results: Our findings showed a significant increase in the frequency of CD103 Conclusion: The data indicate that circulating higher frequency of CD103

Indexed as

Antigens, CDCD8-Positive T-LymphocytesIntegrin alpha ChainsProgrammed Cell Death 1 ReceptorReceptors, ImmunologicAdolescentAdultChildChild, PreschoolFemaleHumansImmunologic MemoryLeukemiaLeukemia, Myeloid, AcuteMaleMemory T Cellsalpha E integrinsAntigens, CDIntegrin alpha ChainsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, ImmunologicTIGIT protein, humanCD103+CD8+ T cellsimmune checkpointsleukemiaPD-1T cell exhaustionTIGITtissue resident memory T cells

Identifiers

PMID39391310
PMCPMC11465237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.